(State or other jurisdiction of incorporation)
(IRS Employer Identification No.)
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (17 CFR 230.405) or Rule 12b-2 of the Exchange Act (17 CFR 240.12b-2).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Results of Operations and Financial Condition.
Submission of Matters to a Vote of Security Holders
The Annual Meeting of Shareholders of the Company was held on September 19, 2018 in Orlando, Florida. On September 19, 2018, Peter W. Descovich, the independent Inspector of Election for the Annual Meeting, delivered to the Company his final, certified vote results.
The name of each director elected at the meeting, a brief description of each other matter voted upon, and the voting results, are provided below. At the Annual Meeting, the shareholders took the following actions:
Voted on the election of 8 directors to serve until the next annual meeting of shareholders and until their successors are elected and qualified, as follows:
Margaret Shân Atkins
James P. Fogarty
Cynthia T. Jamison
Eugene I. Lee, Jr.
William S. Simon
Charles M. Sonsteby
Timothy J. Wilmott
Approved a resolution providing advisory approval of the Company’s executive compensation.
Ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending May 26, 2019.
Did not approve the shareholder proposal requesting that the Company issue a report on the feasibility of adopting a policy to eliminate the use of medically important antibiotics for disease prevention in its supply chain.
Financial Statements and Exhibits.
DARDEN RESTAURANTS, INC.
/s/ Ricardo Cardenas
Senior Vice President and Chief Financial Officer